CompletedPhase 3NCT06037408

The Effect of N115 on Coughing in IPF Patients

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cellular Sciences, inc.
Principal Investigator
Manuel M Lam, MD
Family First Medical Research Center
Intervention
20mM sodium pyruvate nasal spray(drug)
Enrollment
50 target
Eligibility
40-80 years · All sexes
Timeline
2023 – 2024

Study locations (1)

Collaborators

Family First Medical Research Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06037408 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials